|
|
|
|
|
Phase II study of adjuvant imatinib mesylate (IM) in patients after resection of primary gastrointestinal stromal tumor (GIST): Efficacy and safety at one year. |
2555 |
# |
|
|
|
|
|
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma. |
2557 |
# |
|
|
|
|
|
Phase II Consolidation Chemotherapy With Ifosfamide and Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Cervix Uteri |
2554 |
# |
|
|
|
|
|
Phase II clinical trial of Ayurved Siriraj Wattana Recipe for symptomatic relief in patients with osteoarthritis of the knee. |
2555 |
# |
|
|
|
|
|
Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma |
2554 |
# |
|
|
|
|
|
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma |
2560 |
# |
|
|
|
|
|
PHASE 3 STUDY OF FRONTLINE RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE PLUS VINCRISTINE (R-CHOP) OR BORTEZOMIB (VR-CAP) IN TRANSPLANTATION-UNSUITABLE MANTLE CELL LYMPHOMA (MCL) PATIENTS |
2557 |
# |
|
|
|
|
|
Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1% |
2561 |
# |
|
|
|
|
|
Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 |
2560 |
# |
|
|
|
|
|
Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia |
2562 |
# |
|
|
|
|
|
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma |
2555 |
# |
|
|
|
|
|
PHARMCOKINETICS, SAFETY AND ANTIVIRAL ACTIVITY OF CMX157, A NOVEL PRODRUG OF TENOFOVIR, ADMINISTERED AS ASCENDING MULTIPLE DOSES TO HBV-INFECTED SUBJECTS. |
2560 |
# |
|
|
|
|
|
Pharmacological Assessment of Efavirenz Weight-Band Dosing Recommendations in HIV-Infected Thai Children |
2556 |
# |
|
|
|
|
|
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region |
2559 |
# |
|
|
|
|
|
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial |
2565 |
# |
|
|
|
|
|
Pharmacokinetics, Safety, and Efficacy of Maraviroc in Treatment-Experienced Pediatric Patients Infected With CCR5-Tropic HIV-1. |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) single-tablet regimen in HIV-1-infected children (6 to < 12 years) |
2561 |
# |
|
|
|
|
|
Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjects |
2560 |
# |
|
|
|
|
|
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically-suppressed HIV-1-infected adolescents. |
2560 |
# |
|
|
|
|
|
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. |
2548 |
# |
|
|
|
|
|
Pharmacokinetics of Nevirapine in HIV and Tuberculosis-coinfected Children Receiving Antiretroviral Fixed-dose Combination Tablets While Receiving Rifampicin-containing Tuberculosis Treatment and After Rifampicin Discontinuation |
2555 |
# |
|
|
|
|
|
Pharmacokinetics Of Epinephrine Absorption via Intranasal Administration: A Preliminary Report |
2553 |
# |
|
|
|
|
|
Pharmacokinetics of cucurbitacin B from Trichosanthes cucumerina L. in rats |
2562 |
# |
|
|
|
|
|
Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in End-Stage Renal Disease Patients Receiving Continuous Ambulatory Peritoneal Dialysis |
2557 |
# |
|
|
|
|
|
Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates. |
2559 |
# |
|
|
|
|
|
Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study |
2557 |
# |
|
|
|
|
|
Pharmacokinetics and safety of maraviroc in neonates |
2564 |
# |
|
|
|
|
|
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children |
2554 |
# |
|
|
|
|
|
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children. |
2557 |
# |